Back to Search
DAVID WENNING, PHARMD
PHARMD
Pharmacist
NPI: 1669018214Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
26026647A(IN)
Research & Publications (9)
Bortezomib, dexamethasone, and fibroblast growth factor receptor 3-specific tyrosine kinase inhibitor in t(4;14) myeloma.
PMID 19147757·Clin Cancer Res·2009
8-other
Recurrent acute liver failure and mitochondriopathy in a case of Wolcott-Rallison syndrome.
PMID 18704764·J Inherit Metab Dis·2008
5-case
Indications for pediatric liver transplantation. Data from the Heidelberg pediatric liver transplantation program.
PMID 17890259·Nephrol Dial Transplant·2007
8-other
Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups.
PMID 16278310·Blood·2006
8-other
Bortezomib in combination with dexamethasone for relapsed multiple myeloma.
PMID 15755512·Leuk Res·2005
8-other
Recruitment of p300 by C/EBPbeta triggers phosphorylation of p300 and modulates coactivator activity.
PMID 12574124·EMBO J·2003
8-other
Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma.
PMID 12517814·Blood·2003
8-other
Crosstalk between Myc and activating transcription factor 2 (ATF2): Myc prolongs the half-life and induces phosphorylation of ATF2.
PMID 11781825·Oncogene·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 202 S MAIN ST
RUSHVILLE, IN 46173 - Phone
- (765) 938-3155
Quick Facts
- NPI
- 1669018214
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 9
Are you this provider?
Claim Your Profile